TY - JOUR
T1 - Evaluation of analgesic efficacy and opioid sparing effect of pregabalin after arthroscopic rotator cuff repair surgery
T2 - A retrospective cohort study
AU - Chae, Sang Hoon
AU - Lee, Je Eun
AU - Kim, Myo Jong
AU - Yoo, Jae Chul
N1 - Publisher Copyright:
© 2020 The Japanese Orthopaedic Association
PY - 2021/7
Y1 - 2021/7
N2 - Background: Considering the adverse effects of opioids, it is essential to minimize their consumption for postoperative pain control. Studies have reported the opioid sparing effects of pregabalin, with conflicting results. Evidence for administering pregabalin in a multimodal regimen after arthroscopic rotator cuff repair surgery is limited. Methods: A total of 64 patients who underwent arthroscopic rotator cuff repair were enrolled in the cohort, and their data were retrospectively analyzed to evaluate the ability of pregabalin for postoperative analgesia and opioid sparing. The pregabalin group (n = 32) received additional pregabalin 75 mg for 2 weeks from the day before the surgery with the standard pain medications; in contrast, the control group (n = 32) was prescribed the standard pain medications alone. The total volume of patient-controlled anesthesia, doses of oral oxycodone and intravenous morphine as rescue analgesics, number of adverse events, and patient satisfaction based on the numeric rating scale (0–10) were assessed. Further, we used the visual analog scale for evaluating pain and function for 6 months in each group. Results: Total patient-controlled anesthesia volume, number of patient-controlled anesthesia attempts on the day of surgery, and total oral oxycodone consumption were significantly lower in the pregabalin group. Visual analog scale scores for pain and function showed no significant differences. Although the total number of adverse effects (nausea, vomiting, dizziness, dry mouth, urinary retention, itching sense, or constipation) was higher in the pregabalin group than in the control group, the difference was not statistically significant. Conclusion: Our multimodal regimen with pregabalin significantly reduced opioid consumption with similar adverse effects. However, there was no significant difference in the pain score. We recommend pregabalin as an additional analgesic for arthroscopic rotator cuff repairs, especially for medium to large sized tears.
AB - Background: Considering the adverse effects of opioids, it is essential to minimize their consumption for postoperative pain control. Studies have reported the opioid sparing effects of pregabalin, with conflicting results. Evidence for administering pregabalin in a multimodal regimen after arthroscopic rotator cuff repair surgery is limited. Methods: A total of 64 patients who underwent arthroscopic rotator cuff repair were enrolled in the cohort, and their data were retrospectively analyzed to evaluate the ability of pregabalin for postoperative analgesia and opioid sparing. The pregabalin group (n = 32) received additional pregabalin 75 mg for 2 weeks from the day before the surgery with the standard pain medications; in contrast, the control group (n = 32) was prescribed the standard pain medications alone. The total volume of patient-controlled anesthesia, doses of oral oxycodone and intravenous morphine as rescue analgesics, number of adverse events, and patient satisfaction based on the numeric rating scale (0–10) were assessed. Further, we used the visual analog scale for evaluating pain and function for 6 months in each group. Results: Total patient-controlled anesthesia volume, number of patient-controlled anesthesia attempts on the day of surgery, and total oral oxycodone consumption were significantly lower in the pregabalin group. Visual analog scale scores for pain and function showed no significant differences. Although the total number of adverse effects (nausea, vomiting, dizziness, dry mouth, urinary retention, itching sense, or constipation) was higher in the pregabalin group than in the control group, the difference was not statistically significant. Conclusion: Our multimodal regimen with pregabalin significantly reduced opioid consumption with similar adverse effects. However, there was no significant difference in the pain score. We recommend pregabalin as an additional analgesic for arthroscopic rotator cuff repairs, especially for medium to large sized tears.
UR - https://www.scopus.com/pages/publications/85089663093
U2 - 10.1016/j.jos.2020.07.013
DO - 10.1016/j.jos.2020.07.013
M3 - Article
C2 - 32839073
AN - SCOPUS:85089663093
SN - 0949-2658
VL - 26
SP - 599
EP - 603
JO - Journal of Orthopaedic Science
JF - Journal of Orthopaedic Science
IS - 4
ER -